Baystate Wealth Management’s Veracyte VCYT Stock Holding History

Baystate Wealth Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2	Closed	–	–	766
2020 Q3	$0	Buy	+2	New	+$64	﹤0.01%	745

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baystate Wealth Management's VCYT Position: Q4 2020 in Review

Baystate Wealth Management sold out of Veracyte (VCYT) in Q4 2020, closing a stake of 2 shares.

Baystate Wealth Management first reported a position in VCYT in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 222 funds tracked by Wall St. Rank hold VCYT as of Q4 2020.

Baystate Wealth Management reported no remaining Veracyte position as of Q4 2020 after selling out during the quarter.
Baystate Wealth Management sold 2 Veracyte shares in Q4 2020.
Baystate Wealth Management first reported a position in Veracyte in Q3 2020 and held it in 1 quarter.
Baystate Wealth Management's Veracyte position peaked at $0 in Q3 2020.
222 funds tracked by Wall St. Rank held Veracyte as of Q4 2020.

Based on Baystate Wealth Management's 13F filing for Q4 2020, filed 15 Jan 2021.